RE:RE:More ISDIN Products launch in this quarter I don't think that Pliaglis sales in Mexico and Canada will be that large relative to the US, assuming a modest royalty.
Perhaps another $1 million or so.
But, sales of Intega products in the US, aggressively promoted, could be of the order of $45 million , as previously outlined in a recent post.
Crescita currently trades at just 0.71 of hard book which is less than its cash.
With annual sales in 2017 easily doubling those of 2016, it's a no brainer to add more at these prices.
We have a former President of Valeant who recently joined our BOD , plus our new CEO is a former Valeant employee and we have Sachria who was the CFO of Paladin and current President of GUD who are now running CTX.
This combo of great management , superb balance sheet and strong growth profile should get us to the $10 mark over the next 12 to 18 months.... based on current peer valuation multiples